|
1991-1995
Doré S, Brisson GR, Fournier A, Massicotte D, Péronnet F, Gareau R. HGH20K species and variability of GH responses to long-duration exercise in male cyclists fed different food supplements. Horm Metab Res 23:431-4, 1991.
Doré S, Brisson GR, Fournier A, Montpetit R, Perrault H, Boisvert D. Contribution of the hGH20K variant to blood hGH response in sauna and exercise. Eur J Appl Physiol 62:130-4, 1991.
Doré S, Pelletier JP, DiBattista JA, Tardif G, Brazeau P, Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation: Possible role of IGF-1 binding proteins. Arthritis Rheum 37:253-63, 1994.
Doré S, Abribat T, Rousseau N, Brazeau P, Tardif G, DiBattista JA, Cloutier J-M, Pelletier JP, Martel-Pelletier J. Increased insulin-like growth factor I production by human osteoarthritic chondrocytes is not dependent on growth hormone action. Arthritis Rheum 38: 413-19, 1995.
Schmidt W, Doré S, Hilgendorf A, Strauch S, Gareau R, Brisson GR. Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor-I axis. Eur J Appl Physiol 71:424-30, 1995.
1996-1997
Tavera C, Abribat T, Reboul P, Doré S, Brazeau P, Pelletier JP, Martel-Pelletier J. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoartritis Cartilage 4:263-74, 1996.
DiBattista JA, Doré S, Morin N, Abribat T. Prostaglandin E2 up-regulates insulin-like growth factor binding protein-3 expression and synthesis in human articular chondrocytes by a cAMP-independent pathway: Role of calcium and protein kinase A and C. J Cell Biochem 63:320-33, 1996.
DiBattista JA, Doré S, Martel-Pelletier J, Pelletier JP. Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: Identification of an effector autocrine loop involving insulin-like growth factor I. Mol Cell Endocrinol 123:27-35, 1996.
Doré S, Krieger C, Kar S, Quirion R. Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients. Brain Res Mol Brain Res 41:128-33, 1996.
Doré S, Kar S, Quirion R. Emploi thérapeutique de l’IGF-I dans le traitement de maladies neurodégénératives. Médecine/Sciences 13:557-65, 1997.
Doré S, Kar S, Quirion R. Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons. Neuroscience 78:373-83, 1997.
DiBattista JA, Doré S, Morin N, He Y, Pelletier JP, Martel-Pelletier J. Prostaglandin E2 stimulates insulin-like growth factor binding protein-4 expression and synthesis in cultured human articular chondrocytes. Possible mediation by Ca2+-calmodulin regulated processes. J Cell Biochem 65:408-19, 1997.
Doré S, Kar S, Rowe W, Quirion R. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience 80:1033-40, 1997.
Doré S, Kar S, Quirion R. Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases. Trends Neurosci 20:326-31, 1997.
Doré S, Kar S, Quirion R. Utilization of IGF-I for the treatment of neurological disorders. Selections of the Médecine/Sciences 7:40-7, 1997.
Doré S, Kar S, Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against ß-amyloid and human amylin-induced toxicity. Proc Natl Acad Sci U S A 94:4772-7, 1997.
Kar S, Seto D, Doré S, Chabot JG, Quirion R. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation. Neuroscience 80:1041-55, 1997.
Kar S, Seto D, Doré S, Hanisch UK, Quirion R. Insulin-like growth factor-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proc Natl Acad Sci U S A 94:14054-9, 1997.
1998-1999
Doré S, Kar S, Auld D, Chabot JG, Quirion R. Autoradiographic localization of growth factor receptors in neuronal tissues: Insulin-like growth factors as a prototypical example. Curr Prot Pharmacol 8.2.1-16, 1998.
Chabot JG, Dumont Y, St-Pierre JA, Tong Y, Doré S, Kar S, Quirion R. Anatomical approaches to study G-protein coupled peptide receptors. In: P. Geppetti, W. Muller-Esterl, D. Regoli, et al., ed., Peptidergic G protein-coupled receptors: from basic research to clinical application. Amsterdam, Netherlands: IOS Press, pp. 11-28, 1999.
Doré S, Kar S, Chabot JG, Quirion R. Impact of neonatal kainate treatment on hippocampal insulin-like growth factor receptors. Neuroscience 91:1035-43, 1999.
Doré S, Bastianetto S, Kar S, Quirion R. Protective and rescuing abilities of IGF-I and some putative free radical scavengers against ß-amyloid-inducing toxicity in neurons. Ann N Y Acad Sci 890:356-64, 1999.
Doré S, Snyder SH. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci 890:167-72, 1999.
Doré S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96:2445-50, 1999.
Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Doré S, Poss KD, Snyder SH. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1:152-7, 1999.
Doré S, Sampei K, Goto S, Alkayed N, Guastella D, Blackshaw S, Gallagher M, Traystman RJ, Hurn PD, Koehler RC, Snyder SH. Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med 5:656-63, 1999.
2000-2001
Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by ß-amyloid. Eur J Neurosci 12:1882-90, 2000.
Zheng WH, Doré S, Kar S, Quirion R. Insulin-like growth factor-I (IGF-1): A neuroprotective trophic factor acting via the Akt kinase pathway. J Neural Transm Suppl 60:261-72, 2000.
Doré S*, Law A*, Blackshaw S, Gauthier S, Quirion R. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience 100:769-75, 2000. Corrigendum
(*These authors contributed equally to this work.)
Doré S*, Goto S*, Sampei K, Blackshaw S, Hester LD, Ingi T, Sawa A, Traystman RJ, Koehler RC, Snyder SH. Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia. Neuroscience 99:587-92, 2000. (*These authors contributed equally to this work.)
Doré S, Kar S, Zheng WH, Quirion R. Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer’s disease and stroke. Pharm Acta Helv 74:273-80, 2000.
Doré S*, Takahashi M*, Ferris CD, Tomita T, Sawa A, Wolosker H, Borchelt DR, Iwatsubo T, Kim SH, Thinakaran G, Sisodia S, Snyder SS. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28:461-73, 2000. (*These authors contributed equally to this work.)
Doré S, Quirion R. IGF-I, insulin, brain glucose, and cognition. In: The Corsini Encyclopedia of Pshychology and Behavioral Science, Vol 2. WE Craighead, CB Nemeroff, eds., John Wiley & Sons, Hoboken, NJ. 728-33, 2001.
Baranano DE, Doré S, Ferris CD, Snyder SH. Physiologic roles for the heme oxygenase products carbon monoxide, bilirubin, and iron: Links to neuroprotection in stroke and Alzheimer’s disease. Clin Neurosci Res 1:46-52, 2001.
2002-2003
Doré S. Decreased activity of the antioxidant hemeoxygenase enzyme: implications in ischemia and in Alzheimer’s disease. Free Radic Biol Med 32:1276-82, 2002.
Zhuang H, Pin S, Christen Y, Doré S. Induction of heme oxygenase by Ginkgo biloba in neuronal cultures and potential implications in ischemia. Cell Mol Biol 48:647-53, 2002.
Zhuang H, Kim Y-S, Koehler RC, Doré S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci 993:276-86, 2003.
Zhuang H, Pin S, Li X, Doré S. Regulation of heme oxygenase by cyclopentenone prostaglandins. Exp Biol Med 228:499-505, 2003.
Zhuang H, Kim Y-S, Namiranian K, Doré S. Prostaglandins of J series control heme oxygenase expression: Potential significance in modulating neuroinflammation. Ann N Y Acad Sci 993:208-16, 2003.
Goto S, Sampei K, Alkayed NJ, Doré S, Koehler RC. Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice. Am J Physiol Regul Integr Comp Physiol 285(1):R222-30, 2003.
Doré S, Otsuka T, Mito T, Sugo N, Hand T, Wu L, Hurn PD, Traystman RJ, Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol Aug;54(2):155-62, 2003. Editorial in: Ann Neurol. 2003 Aug;54(2):141-2.
2004-2005
Cowan RL, Doré S. Toxicity and neuroprotective effects of carbon monoxide: consequences to suicide and survival. In: The Concise Corsini Encyclopedia of Psychology and Behavioral Science. WE Craighead, CB Nemeroff, eds., John Wiley & Sons, Hoboken, NJ, 994-997, 2004.
Doré S, Kofler J, Quirion R. The insulin-like growth factor I: a key modulator of neurogenesis and cognitive functions. In: The Concise Corsini Encyclopedia of Psychology and Behavioral Science WE Craighead, CB Nemeroff, eds., John Wiley & Sons, Hoboken, NJ, 460-466, 2004.
Tao F, Tao Y-X, Zhao C, Doré S, Liaw W-J, Raja SN, Johns RA. Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia. Neuroscience 128:421-30, 2004.
Kim YS, Zhuang H, Koehler RC, Doré S. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic Biol Med 38:85-92, 2005.
Namiranian K, Koehler RC, Sapirstein, A, Doré S. Stroke outcomes in mice lacking the genes for neuronal heme oxygenase-2 and nitric oxide synthase. Curr Neurovasc Res 2:23-7, 2005.
Doré S. Unique properties of polyphenol stilbenes in the brain: more than direct antioxident actions; gene/protein regulatory activity. Neurosignals 14:61-70, 2005.
Zhuang, H, Littleton-Kearny, MT, Doré S. Characterization of heme oxygenase in adult rodent platelets. Curr Neurovasc Res 2:163-8, 2005.
Kim YS, Doré S. Catalytically inactive heme oxygenase-2 mutant is cytoprotective. Free Radic Biol Med 39:558-64, 2005.
Echeverria V, Clerman A, Doré S. Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure. Eur J Neurosci 22 (9):2199-206, 2005.
Echeverria V, Greenberg DL, Doré S. Expression of prostaglandin E2 synthases in mouse postnatal cortical neurons. Ann NY Acad Sci 1053:460-71, 2005.
Ahmad AS, Ahmad M, de Brum-Fernandes AJ, Doré S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 1066:71-7, 2005.
2006
Ahmad AS, Saleem S, Ahmad M, Doré S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89(1):265-270, 2006.
Rebel A, Cao S, Kwansa H, Doré S, Bucci E, Koehler, RC. Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin. Am J Physiol Heart Circ Physiol 290:1027-37, 2006.
Wang J, Zhuang H, Doré S. Heme oxygenase 2 is neuroprotective against intracerebral hemorrhage. Neurobiol Dis 22(3):473-6, 2006.
Ahmad M, Saleem S, Zhuang H, Ahmad AS, Echeverria V, Sapirstein A, Doré S. 1-HydroxyPGE1 reduces infarction volume in mouse transient cerebral ischemia. Eur J Neurosci 23(1):35-42 2006.
Shah ZA, Namiranian K, Klaus J, Kibler K, Doré S. Use of an optimized transient occlusion of the middle cerebral artery protocol for the mouse stroke model. J Stroke Cerebrovasc Dis, 15(4):133-8, 2006.
Ahmad AS, Zhuang H, Doré S. Heme oxygenase-1 protects brain from acute excitotoxcity. Neuroscience 141(4):1703-8, 2006.
Doré S. GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor. Trends Pharmacol Sci 27(9):458-60, 2006.
Ahmad AS, Zhuang H, Echeverria V, Doré S. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity. J Neurotrauma 23(12), 1895-903, 2006.
2007
Wang J, Doré, S. Inflammation after Intracerebral Hemorrhage. J Cereb Blood Flow Metab. 27(5):894-908, 2007.
Ahmad M, Ahmad AS, Zhuang H, Maruyama T, Narumiya S, Doré S. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury. J Neuroimmunol 184(1-2), 172-9, 2007.
Wang J, Doré S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 130:1643-52, 2007.
Shah ZA, Li RC, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S, Doré S. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience. 147:53-9, 2007.
Saleem S, Li Rung-chi, Wei G, Doré S. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J Neurosci Res. 85:2433-2440, 2007.
Wang J, Fields J, Zhao C, Langer J, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S, Doré S. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic Biol Med. 43:408-14 2007.
Saleem S, Zhuang H, de Brum-Fernandes AJ, Maruyama T, Narumiya S, Doré S. PGD2 DP1 receptor protects brain from ischemia-reperfusion injury. Eur J Neurosci, 26:73-78, 2007.
Levine CF, Li RC, Shah ZA, Doré S. Resveratrol and neurodegenerative diseases. In: Watson RR, Preedy VR (eds) The Encyclopedia of Botanicals in Clinical Practice. CABI Publishing, Wallingford, UK, In press, 2007.
Zhen G, Doré S. Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice. J Neurosci Methods, In press, 2007.
2008
Kim YT, Yi Y-J, Kim M-Y, Bu Y, Jin ZH, Choi H, Doré S, Kim H. Neuroprotection and enhancement of spatial memory by herbal mixture HT008-1 in rat global brain ischemia model. Am. J. Chinese Medicine 36:287-99, 2008.
Chaudhry UA, Zhuang H, Crain BJ, Doré S. Elevated microsomal prostaglandin E synthase-1 in Alzheimer disease. Alzheimer’s & Dementia, 4:6-13, 2008.
Kim J, Chung SY, Park S, Park J-H, Byun S, Hwang M, Oh D-S, Choi H, Kim M-Y, Bu Y, Doré S, Whang W-W, Kim H. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial. Pharmacol, Biochem Behav, [Epub ahead of print], April 1, 2008
Choi K, Zhuang H, Crain B, Doré S. Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls. J Neuroimmunol. 195:81-7, 2008.
Kim YS, Guastella D, Doré S. Neuroprotective role of heme oxygenase-2 in 6-hydroxydopamine-lesioned mouse. New Trends in Alzheimer and Parkinson disorders, 201-208, 2008.
Qin X, Kwansa H, Bucci E, Doré S, Boehning D, Shugar D, Koehler RC. Role of heme oxygenase-2 in pial arteriolar response to acetylcholine in mice with and without transfusion of cell-free hemoglobin polymers. Am. J Physiol: Reg, Integr. Comp. Physiol. [Epub ahead of print], May 21, 2008.
Wang J, Fields J, Doré S. The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood. Brain Research, In Press 2008.
Saleem S; Zhuang H, Biswal S, Christen Y, Doré S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke, In Press, 2008.
Wang J, Doré S. Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage. Neuroscience, In Press, 2008.
|
